Šaňák Daniel, Divišová Petra, Hutyra Martin, Král Michal, Bártková Andrea, Zapletalová Jana, Látal Jan, Dorňák Tomáš, Hudec Štěpán, Franc David, Polidar Petr, Veverka Tomáš, Kaňovský Petr
Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic.
Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and Hospital, Olomouc, Czech Republic.
J Neurol Sci. 2020 Sep 15;416:116985. doi: 10.1016/j.jns.2020.116985. Epub 2020 Jun 13.
Elderly cryptogenic ischemic stroke (IS) patients with embolic stroke of undetermined source (ESUS) have a high risk of recurrent IS (RIS) compared to other stroke subtypes. In young ESUS patients, different sources of embolism may be a cause and the risk of RIS remains not enough established. The aim was to assess and compare risk of RIS between ESUS and non ESUS patients <50 years.
The study set consisted of young acute IS patients <50 years enrolled in the prospective HISTORY (Heart and Ischemic STrOke Relationship studY) study registered on ClinicalTrials.gov (NCT01541163). In all analyzed patients, the brain ischemia was confirmed on CT or MRI. All patients underwent identical diagnostic protocol including TEE and long-term ECG-Holter. Cause of IS was assessed according to the ASCOD classification.
Of 320 enrolled patients <50 years, 219 (68.4%) were identified as cryptogenic (119 males, mean age 41.4 ± 7.2 years) and 122 (38.1%) patients fulfilled the ESUS criteria. During the follow-up with a median of 34 months, three (2.5%) ESUS and 5 (5.2%) non-ESUS patients suffered from RIS (p = .471). One-year risk of RIS was 0.008 (95% CI: 0-0.025) for ESUS and 0.036 (95% CI: 0-0.076) for non-ESUS patients (p = .262).
The risk of RIS was very low in ESUS patients and did not differ from those with non-ESUS. Our finding may indicate that antiplatelet therapy can be effective in the secondary prevention in young ESUS patients if high-risk sources of embolization are excluded extensively.
与其他卒中亚型相比,老年不明原因栓塞性卒中(ESUS)的隐源性缺血性卒中(IS)患者复发IS(RIS)风险较高。在年轻的ESUS患者中,不同的栓塞来源可能是一个原因,且RIS风险仍未完全明确。本研究旨在评估和比较年龄小于50岁的ESUS患者和非ESUS患者的RIS风险。
研究对象为年龄小于50岁的急性IS年轻患者,这些患者纳入了在ClinicalTrials.gov(NCT01541163)注册的前瞻性HISTORY(心脏与缺血性卒中关系研究)研究。在所有分析的患者中,通过CT或MRI确认脑缺血。所有患者均接受相同的诊断方案,包括经食管超声心动图(TEE)和长期心电图动态监测(ECG-Holter)。根据ASCOD分类评估IS病因。
在320例年龄小于50岁的入选患者中,219例(68.4%)被确定为隐源性(119例男性,平均年龄41.4±7.2岁),122例(38.1%)患者符合ESUS标准。在中位随访34个月期间,3例(2.5%)ESUS患者和5例(5.2%)非ESUS患者发生RIS(p = 0.471)。ESUS患者的1年RIS风险为0.008(95%CI:0 - 0.025),非ESUS患者为0.036(95%CI:0 - 0.076)(p = 0.262)。
ESUS患者的RIS风险非常低,与非ESUS患者无差异。我们的研究结果可能表明,如果广泛排除高风险栓塞来源,抗血小板治疗在年轻ESUS患者的二级预防中可能有效。